Marinus Pharmaceuticals Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 166

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 10

Marinus Pharmaceuticals General Information

Description

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 5 Radnor Corporate Center, 100 Matsonford Road
  • Suite 500
  • Radnor, PA 19087
  • United States
+1 (484)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Former Stock Listing
MRNS
Corporate Office
  • 5 Radnor Corporate Center, 100 Matsonford Road
  • Suite 500
  • Radnor, PA 19087
  • United States
+1 (484)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Marinus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Marinus Pharmaceuticals‘s full profile, request access.

Request a free trial

Marinus Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializi
Drug Discovery
Radnor, PA
166 As of 2023

Cambridge, MA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Marinus Pharmaceuticals Competitors (58)

One of Marinus Pharmaceuticals’s 58 competitors is Alnylam Pharmaceuticals, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Aclaris Therapeutics Formerly VC-backed Wayne, PA
You’re viewing 5 of 58 competitors. Get the full list »

Marinus Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Marinus Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Marinus Pharmaceuticals‘s full profile, request access.

Request a free trial

Marinus Pharmaceuticals FAQs

  • When was Marinus Pharmaceuticals founded?

    Marinus Pharmaceuticals was founded in 2003.

  • Where is Marinus Pharmaceuticals headquartered?

    Marinus Pharmaceuticals is headquartered in Radnor, PA.

  • What is the size of Marinus Pharmaceuticals?

    Marinus Pharmaceuticals has 166 total employees.

  • What industry is Marinus Pharmaceuticals in?

    Marinus Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Marinus Pharmaceuticals a private or public company?

    Marinus Pharmaceuticals is a Private company.

  • What is the current valuation of Marinus Pharmaceuticals?

    The current valuation of Marinus Pharmaceuticals is .

  • What is Marinus Pharmaceuticals’s current revenue?

    The current revenue for Marinus Pharmaceuticals is .

  • How much funding has Marinus Pharmaceuticals raised over time?

    Marinus Pharmaceuticals has raised $217M.

  • Who are Marinus Pharmaceuticals’s investors?

    Avoro Capital, Bain Capital Life Sciences, Canaan Partners, Connecticut Innovations, and Domain Associates are 5 of 14 investors who have invested in Marinus Pharmaceuticals.

  • Who are Marinus Pharmaceuticals’s competitors?

    Alnylam Pharmaceuticals, ACADIA Pharmaceuticals, Vertex Pharmaceuticals, Sarepta Therapeutics, and Aclaris Therapeutics are some of the 58 competitors of Marinus Pharmaceuticals.

  • When was Marinus Pharmaceuticals acquired?

    Marinus Pharmaceuticals was acquired on 07-Feb-2025.

  • Who acquired Marinus Pharmaceuticals?

    Marinus Pharmaceuticals was acquired by Immedica Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process